A multi-institutional historical cohort study assessing the efficacy of salvage therapies after failure of anti-PD-1 monotherapy in patients with advanced melanoma in Asia
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Antineoplastics (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 09 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress